Recombinant hFOXA2 and hPDX1 lentivirus induced dental pulp stem cells from deciduous teeth reprogramming for insulin-producing cells

Abstract

Abstract: PURPOSE: The purpose of this study was to culture and identify dental pulp stem cells(DPSCs) from deciduous teeth in vitro and construct the recombinant hFOXA2 and hPDX1 lentivirus vectors and transfect the DPSCs to induce insulin-producing cells (IPCs). METHODS: DPSCs were separated and cultured by enzyme digest method, and purified by limited dilution method. Flow cytometry was used to determine the surface marker expression of the DPSCs, and the ability of multiple differentiations was determined by specific staining. hFOXA2 and hPDX1 genes were amplified by PCR, and the recombinant hFOXA2 and hPDX1 lentivirus vectors were reconstructed and transfected into 293T cells by lipofectamine2000 for virus packaging. The viral infection efficiency and titer were determined through fluorescence cell count. The recombinant virus was used to infect the DPSCs cells via multiplicity of infection(MOI)and induce the DPSCs reprogramming for IPCs. Immunofluorescence staining was used to measure the expression of proinsulin, FOXA2 and PDX1. ELISA method was used to detect the insulin secretion. The data was analyzed Using SPSS13.0 software package. RESULTS: DPSCs were isolated and cultured successfully. Cell surface highly expressed STRO-1 (98.01%), CDl46 (98.51%), CD34 (99.54%) and CD45 (24.08%). The multi-lineage differentiation capacity into osteoblasts, chondrocytes, and adipose was achieved. The recombinant hFOXA2 and hPDX1 lentivirus vectors were successfully constructed. Double enzyme digestion and sequencing appraisal showed that the sequence was fully consistent with GenBank retrieval. Virus packing efficiency was (96.15±0.17) % and (95.49±0.21) % respectively, and the infection titer was about 1.80×108 GTU/mL. The best MOI of the virus was 20. After inducing the cells to express proinsulin, FOXA2 and PDX1, insulin secretion volume was about 1.92 μmol/L. Compared with the uninduced group and control group, insulin secretion increased significantly (P<0.01). CONCLUSIONS: The recombinant transcription factor virus can activate cell reprogramming mechanism, form insulin-producing cells, and can be used for gene therapy of diabetes seed cells.

Key words: Deciduous dental pulp stem cell, Surface marks, Induced differentiation, Cell programming, Insulin secretion

CLC Number:

R781.3

SHI Jian-feng, ZHU Chun-hui, LIU Jin, SUN Jun-yi, RAO Guo-zhou, LI Ang. Recombinant hFOXA2 and hPDX1 lentivirus induced dental pulp stem cells from deciduous teeth reprogramming for insulin-producing cells[J]. Shanghai Journal of Stomatology, 2013, 22(6): 634-642.

References

[1] Lee TC, Barshes NR, Agee EE, et al. The effect of whole organ pancreas transplantation and PIT on diabetic complications [J]. Curr Diab Rep, 2006, 6(4): 323-327.
[2] Roche E, Reig JA, Campos A, et al. Insulin-secreting cells derived from stem cells: clinical perspectives, hypes and hopes[J]. Transpl Immunol, 2005, 15(2): 113-129.
[3] Koblas T, Zacharovov K, Berkov Z, et al. In vivo differentiation of human umbilical cord blood-derived cells into insulin-producing beta cells [J]. Folia Biol (Praha), 2009, 55(6): 224-232.
[4] Nett PC, Sollinger HW, Alam T. Hepatic insulin gene therapy in insulin-dependent diabetes mellitus [J]. Am J Transplant, 2003, 3(10): 1197-1203.
[5] Alam T, Sollinger HW. Glucose-regulated insulin production in hepatocytes [J]. Transplantation, 2002, 74(12): 1781-1787.
[6] Hao E, Tyrberg B, Itkin-Ansari P, et al. Beta-cell differentiation from nonendoerine epithelial cells of the adult human pancreas[J]. Nat Med, 2006, 12(3): 310-316.
[7] Jiang W, Shi Y, Zhao D, et al. In vitro derivation of functional insulin-producing cells from human embryonic stem cells [J]. Cell Res, 2007, 17(4): 333-344.
[8] McCall MD, Toso C, Baetge EE, et al. Are stem cells a cure for diabetes? [J]. Clin Sci (Lond), 2009, 118(2): 87-97.
[9] Ramiya VK, Maraist M, Arfors KE, et al. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells [J]. Nat Med, 2000, 6(3): 278-282.
[10] Tang DQ, Cao LZ, Burkhardt BR, et al. In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow [J]. Diabetes, 2004, 53(7): 1721-1732.
[11] Zhang W, Walboomers XF, Van Kuppevelt TH, et al. In vivo evaluation of human dental pulp stem cells differentiated towards multiple lineages [J]. J Tissue Eng Regen Med, 2008, 2(2-3): 117-125.
[12] Gronthos S, Zannettino AC. A method to isolate and purify human bone marrow stromal stem cells [J]. Methods Mol Biol,2008, 449: 45-57.
[13] Govindasamy V, Ronald VS, Abdullah AN, et al. Differentiation of dental pulp stem cells into islet-like aggregates [J]. J Dent Res, 2011, 90(5): 646-652.
[14] Bottino R, Lemarchand P, Trucco M, et al. Gene- and cell-based therapeutics for type I diabetes mellitus[J]. Gene Ther,2003,10(10): 875-889.
[15] Zhou Q, Brown J, Kanarek A, et al. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells[J]. Nature,455(7213): 627-632.
[16] Schwitzgebel VM, Scheel DW, Conners JR, et al. Expression of neurogenin3 reveals an islet cell precursor population in the pancreas [J]. Development, 2000, 127(16): 3533-3542.
[17] Taniguchi H, Yamato E, Tashiro F, et al. beta-cell neogenesis induced by adenovirus-mediated gene delivery of transcription factor pdx-1 into mouse pancreas[J].Gene Ther,2003,10(1):15-23.
[18] Miyazaki S, Yamato E, Miyazaki J. Regulated expression of pdx-1 promotes in vitro differentiation of insulin-producing cells from embryonic stem cells [J]. Diabetes, 2004, 53(4): 1030-1037.
[19] Collombat P, Xu X, Ravassard P, et al. The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells [J]. Cell, 2009, 138(3): 449-462.
[20] St George JA. Gene therapy progress and prospects: adenoviral vectors [J]. Gene Ther, 2003, 10(14): 1135-1141.
[21] Wadder R, Russell SJ, Curiel DT. Engineering targeted viral vectors for gene therapy [J]. Nat Rev Genet, 2007, 8(8): 573-587.